CHINA UNIVERSAL AMCHINA UNIVERSAL AMCHINA UNIVERSAL AM

CHINA UNIVERSAL AM

No trades
See on Supercharts

Key stats


Assets under management (AUM)
Fund flows (1Y)
Dividend yield (indicated)
Discount/Premium to NAV
Shares outstanding
Expense ratio
0.60%

About CHINA UNIVERSAL AM


Issuer
China Universal Asset Management Co., Ltd.
Brand
China Universal
Home page
Inception date
Feb 1, 2021
Structure
Open-Ended Fund
Index tracked
National Securities Biomedical Index - CNY - Benchmark TR Gross
Replication method
Physical
Management style
Passive
Dividend treatment
Distributes
Primary advisor
China Universal Asset Management Co., Ltd.
ISIN
CNE100004GG1
Tightly track the target index, and pursue the minimization of tracking deviation and tracking err.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
Vanilla
Geography
China
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of December 31, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks97.88%
Health Technology90.14%
Process Industries6.70%
Commercial Services1.04%
Bonds, Cash & Other2.12%
Cash2.12%
Stock breakdown by region
100%
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


159839 invests in stocks. The fund's major sectors are Health Technology, with 90.14% stocks, and Process Industries, with 6.70% of the basket. The assets are mostly located in the Asia region.
159839 top holdings are WuXi AppTec Co., Ltd. Class A and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class A, occupying 10.02% and 6.29% of the portfolio correspondingly.
No, 159839 doesn't pay dividends to its holders.
159839 shares are issued by China Universal Asset Management Co., Ltd. under the brand China Universal. The ETF was launched on Feb 1, 2021, and its management style is Passive.
159839 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
159839 follows the National Securities Biomedical Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
159839 invests in stocks.